What Are the Best Cannabis Strains for Pain?
April 18th, 2017
Did you know that there are approximately 1.5 billion people around the world suffering with some kind of chronic pain? Dealing with a debilitating ailment, whether it is a torn ligament, a physical impairment following an accident, or something else that usually requires an over-the-counter remedy for relief purposes, can have an adverse effect on one’s life. The inability to attend work, perform daily duties, or even be an active parent can take its toll on health, relationships, and finances. Demand for medical marijuana is growing, as the scientific proof of ganja’s natural alternative for pain relief is surfacing.
Fighting fatigue, curbing depression, managing migraines, relieving cramps, battling anxiety, and treating arthritis are just a few medical advantages associated with the use of certain cannabis strains. But before we start exploring the best cannabis strains for pain management, let’s see how the scientific evidence stacks up, shall we?
A Scientific Scope on Cannabis Strains
According to the National Cancer Institute (NCI), cannabis and cannabinoids are being put in the spotlight by health professionals.While cannabis has not been approved as a treatment for cancer by the U.S. Food and Drug Administration quite yet, the NCI acknowledges that marijuana has been relied on as a form of pain relief for thousands of years. As published on their website:
“Cannabinoids may have benefits in the treatment of cancer-related side effects.”
In 2014, the findings of a study conducted by the National Institutes of Health (NSI) reported a statistically positive benefit in terms of pain relief. These findings were published after a systematic review of randomized controlled trials took place on a group of patients with chronic non-cancer pain.
Popular Cannabis Strains for Pain Management
It is important to know that the THC level varies, depending on the strain you choose. While some strains are unique, others come from stronger “parent strains”. Below, we talk about some of the best cannabis strains to relieve pain:
- Harlequin – Patients who are suffering from arthritis or inflammation will opt for the euphoric, focused, and uplifted feeling that this strain provides its users with. Boasting a high CBD content, it is a popular choice for daytime medication.
- Blue Dream – If you are a fan of puffing sweet-flavored strains of bud that disperse a berry aroma into the air, Blue Dream will be your Holy Grail of pain relief. Expect to feel euphoric and uplifted as you inhale 17-24% THC.
- OG Kush – Said to be a strain of Lemon Thai and Hindu Kush, this cannabis strain has a THC content of 19-26%. Patients use it to treat insomnia, depression and mild pain.
- Jack Herer – With an average THC content of 18-23% and a delicious taste that combines Northern Lights #5 with Shiva Skunk, this cannabis strain definitely deserves a mention. It is useful for treating depression and tiredness.
- White Widow – This strain’s origins come from South America and South Indian indica. Famous worldwide, White Widow combines an earthy taste with a feeling that blends euphoria and pain relief. Try its hybrid cross, Blue Widow.
- Girl Scout Cookies – Also known as GSC, this strain instils a feeling of calm and relaxation. It is a hybrid of the OG Kush and Durban Poison strains. THC content ranges from 17-2%.
In addition to the above cannabis strains for pain relief, a few others deserve a special mention, such as AK-47, Bubba Kush, Green Crack, and Sour Diesel. For migraine relief, try Purple Arrow, or ease cramps with Dynamite or Redwood Kush. Alternatively, take a hit of the CBD and THC-loaded strain that everyone wants to try – ACDC.
Methods of Using Strains for Medical Marijuana Purposes
There are a few ways in which medical marijuana strains can be used to relieve pain associated with problems and/or conditions like spinal injuries and fibromyalgia.
Here are a few options for all you pot advocates out there:
- Smoking a joint
- Smoking a blunt
- Using a water pipe/bong
- “Dabbing” it
- Cooking with it
- Vaporizing it
The use of marijuana in medicine was first supported back in 1999, when a report was published by the Institute of Medicine. As scientific research continues and new, more potent strains are developing, further legizlation is predicted to follow. This, in turn, will likely lead to patients in new locations being offered medical cannabis strains as an alternative to pharmaceutical drugs.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.